Key result
Conventional chemotherapy for paediatric haematological malignancies significantly altered heart rate variability compared to normal controls, indicating autonomic dysfunction.
Why the study?
High-dose chemotherapy and haematopoietic stem cell transplantation carry cardiotoxicity concerns, and heart rate variability differences in paediatric haematological malignancies remain to be characterised.
Does chemotherapy and haematopoietic stem cell transplantation alter heart rate variability in pediatric patients with haematological malignancies?
Cohort (n=70)
Does chemotherapy and haematopoietic stem cell transplantation alter heart rate variability in pediatric patients with haematological malignancies?
Conventional chemotherapy for pediatric hematologic diseases is associated with autonomic dysfunction as measured by heart rate variability, with minor further declines observed after stem cell transplantation.
HRV differences after pediatric chemotherapy suggest autonomic effects; leaves open its value for cardiotoxicity monitoring without prospective validation.
BACKGROUND: High-dose chemotherapy and haematopoietic stem cell transplantation are essential for patients with paediatric haematologic diseases, although cardiotoxicity remains a concern. Heart rate variability analysis can evaluate autonomic nervous function interactions with cardiac function. OBJECTIVE: This study aimed to characterise heart rate variability differences between patients undergoing chemotherapy and controls, and the effects of haematopoietic stem cell transplantation on the autonomic nervous system in patients with haematological malignancies. METHODS: Nineteen patients (11 male, median age: 11.6 years) who received conventional chemotherapy followed by transplantation and 19 non-transplant patients (10 male, median age: 11.5 years) receiving chemotherapy only between 2006 and 2018 for haematological malignancies were retrospectively enrolled. Data from 24-hour Holter monitoring were recorded after chemotherapy and before and after transplantation. Heart rate variability was analysed in patients and 32 matched normal controls. RESULTS: There were significant differences between patients and normal controls in all heart rate variability analysis parameters apart from coefficient of variation of RR interval and standard deviation of the average normal RR interval for all 5-minute segments during sleeping. There was a significant difference in the cumulative anthracycline dose and heart rate variability during sleep between the non-transplant and pre-transplant groups. We observed no remarkable differences in time-domain analysis parameters between before and after transplantation, although the low-frequency component of power-spectrum analysis during awake hours was significantly decreased after transplantation. CONCLUSION: Conventional chemotherapy for paediatric haematologic diseases may be a risk factor for autonomic dysfunction. Further declines in heart rate variability after transplantation appear minor.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2020) conducted a cohort in Paediatric haematological malignancies (n=70). Conventional chemotherapy and haematopoietic stem cell transplantation vs. Matched normal controls was evaluated on Heart rate variability parameters. Conventional chemotherapy for paediatric haematological malignancies significantly altered heart rate variability compared to normal controls, indicating autonomic dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: